By: Marlin Crasta -- Research Analyst, Cost Modelling
20 March, 2018
The pharmaceutical industry has adopted a new approach for producing capsule shells by using vegetable cellulose (HPMC). Despite the high manufacturing cost, it could be a potential alternative to gelatin-based capsules. Manufacturing the capsule shell requires a special pharmaceutical unit operation by the pharmaceutical companies. Traditionally, capsule shells are produced using gelatin as the main raw material. However, buyer preference is eventually shifting towards HPMC capsules due to its quality, stability and vegan properties. This article will discuss the possible shift toward vegetable capsules, the quality and cost advantages associated with the shift and impacts on price.
Capsule Shell Industry Insights The global empty capsules market was valued at USD 1.43 billion in 2016 and is expected to expand at a CAGR of 7.3% over the forecast period (2016-2026). Factors responsible for the growth include the increase in the geriatric population, the high demand for empty capsules in the pharmaceutical, nutraceutical and cosmeceutical industries, and the growing consumer preference for capsules over tablets. Capsules are preferred by most of the consumers due to their fast disintegrating property, which results in quicker absorption rates, and the use of a tasteless and odorless gelatin coating, which makes them palatable.
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)